BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28143858)

  • 1. Phenotyping of adipose, liver, and skeletal muscle insulin resistance and response to pioglitazone in spontaneously obese rhesus monkeys.
    Shang J; Previs SF; Conarello S; Chng K; Zhu Y; Souza SC; Staup M; Chen Y; Xie D; Zycband E; Schlessinger K; Johnson VP; Arreaza G; Liu F; Levitan D; Wang L; van Heek M; Erion M; Wang Y; Kelley DE
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E235-E243. PubMed ID: 28143858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.
    Tozzo E; Bhat G; Cheon K; Camacho RC
    PLoS One; 2015; 10(5):e0126642. PubMed ID: 25954816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
    de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
    Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
    Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
    Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys.
    Pender C; Ortmeyer HK; Hansen BC; Goldfine ID; Youngren JF
    Metabolism; 2002 Apr; 51(4):465-70. PubMed ID: 11912555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.
    Honka MJ; Latva-Rasku A; Bucci M; Virtanen KA; Hannukainen JC; Kalliokoski KK; Nuutila P
    Eur J Endocrinol; 2018 May; 178(5):523-531. PubMed ID: 29535167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
    Gastaldelli A; Harrison SA; Belfort-Aguilar R; Hardies LJ; Balas B; Schenker S; Cusi K
    Hepatology; 2009 Oct; 50(4):1087-93. PubMed ID: 19670459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.
    Stumvoll M; Jacob S; Wahl HG; Hauer B; Löblein K; Grauer P; Becker R; Nielsen M; Renn W; Häring H
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3740-5. PubMed ID: 11061533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
    Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
    Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
    Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
    Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
    Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T
    J Biol Chem; 2006 Mar; 281(13):8748-55. PubMed ID: 16431926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
    Pickavance LC; Brand CL; Wassermann K; Wilding JP
    Br J Pharmacol; 2005 Feb; 144(3):308-16. PubMed ID: 15655531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
    N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women.
    Magkos F; Fabbrini E; Conte C; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1219-23. PubMed ID: 22492868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
    Ye JM; Frangioudakis G; Iglesias MA; Furler SM; Ellis B; Dzamko N; Cooney GJ; Kraegen EW
    Endocrinology; 2002 Dec; 143(12):4527-35. PubMed ID: 12446579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.